1.
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-...
by Cahn, Pedro, Dr
The Lancet infectious diseases, 2014, Vol.14 (7), p.572-580

2.
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
by Molina, Jean-Michel, Dr, Prof
The Lancet (British edition), 2011, Vol.378 (9787), p.238-246

3.
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine
by HAAS, David W
AIDS (London), 2000, Vol.14 (13), p.1973-1978

4.
Antiretroviral Resistance among HIV Type 1-Infected Women First Exposed to Antiretrovirals during Pregnancy : Plasma versus PBMCs
by SOTO-RAMIREZ, Luis E
AIDS research and human retroviruses, 2008, Vol.24 (6), p.797-804
